Cerity Partners LLC Increases Stake in Stryker Corporation $SYK

Cerity Partners LLC boosted its position in Stryker Corporation (NYSE:SYK) by 16.1% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 314,580 shares of the medical technology company’s stock after acquiring an additional 43,511 shares during the period. Cerity Partners LLC owned 0.08% of Stryker worth $124,465,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in SYK. Mid American Wealth Advisory Group Inc. purchased a new stake in shares of Stryker during the 2nd quarter valued at approximately $26,000. Elevation Point Wealth Partners LLC bought a new stake in Stryker during the 2nd quarter valued at $28,000. Sachetta LLC lifted its position in shares of Stryker by 58.7% during the second quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after acquiring an additional 27 shares in the last quarter. Kilter Group LLC bought a new position in shares of Stryker in the second quarter worth $29,000. Finally, Ridgewood Investments LLC grew its position in shares of Stryker by 48.4% in the second quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock valued at $36,000 after purchasing an additional 30 shares in the last quarter. Institutional investors own 77.09% of the company’s stock.

Insider Buying and Selling at Stryker

In other Stryker news, Director Ronda E. Stryker sold 276,173 shares of Stryker stock in a transaction dated Thursday, November 6th. The stock was sold at an average price of $353.28, for a total transaction of $97,566,397.44. Following the completion of the sale, the director owned 2,702,108 shares of the company’s stock, valued at $954,600,714.24. The trade was a 9.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Preston Wendell Wells sold 165 shares of the stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $365.88, for a total value of $60,370.20. Following the transaction, the chief financial officer owned 6,694 shares in the company, valued at $2,449,200.72. This trade represents a 2.41% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 522,118 shares of company stock worth $185,381,932 over the last 90 days. Corporate insiders own 5.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on SYK. Evercore ISI dropped their price objective on Stryker from $410.00 to $405.00 and set an “outperform” rating on the stock in a report on Friday, October 31st. UBS Group set a $408.00 price objective on shares of Stryker in a research report on Monday, October 13th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Stryker in a report on Monday, December 1st. Truist Financial increased their target price on shares of Stryker from $392.00 to $400.00 and gave the stock a “hold” rating in a research note on Friday, November 14th. Finally, Wall Street Zen upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research report on Saturday, October 18th. Twelve equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $433.78.

Stryker Trading Down 0.1%

Shares of Stryker stock opened at $363.82 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.85 and a quick ratio of 1.13. Stryker Corporation has a 1 year low of $329.16 and a 1 year high of $406.19. The firm has a market cap of $139.13 billion, a PE ratio of 47.81, a PEG ratio of 2.58 and a beta of 0.89. The company has a 50 day simple moving average of $368.34 and a two-hundred day simple moving average of $379.39.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, October 30th. The medical technology company reported $3.19 earnings per share for the quarter, beating the consensus estimate of $3.13 by $0.06. Stryker had a net margin of 12.07% and a return on equity of 24.07%. The firm had revenue of $6.06 billion for the quarter, compared to analysts’ expectations of $6.04 billion. During the same quarter last year, the company posted $2.87 EPS. The business’s quarterly revenue was up 10.2% on a year-over-year basis. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. Analysts expect that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.